Etiology distribution of patients with atrial fibrilation by echocardiography: results from a prospective study in 3755 adults Enes Abdovic Cantonal Hospital.

Slides:



Advertisements
Similar presentations
Atrial Fibrillation Service
Advertisements

Screening and diagnosis of AF and stratifying stroke risk.
Stratifying stroke risk to guide antithrombotic therapy in patients with AF.
Dementia IGHC Tatiana Kuznetsova, Jan A. Staessen University of Leuven, Belgium Diagnostic criteria for subclinical systolic and diastolic LV function.
Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
Student’s Research Group at the Department of Internal Medicine, Hypertension and Angiology The Medical University in Warsaw PULMONARY EMBOLISM – TOUGH.
Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
Maria Rosa Costanzo, M.D., F.A.C.C., F.A.H.A. Medical Director, Midwest Heart Specialists-Advocate Medical Group Heart Failure and Pulmonary Arterial Hypertension.
Heart Failure with Normal Systolic Function: Better or Worse Prognosis? Maria Rosa Costanzo, M.D., F.A.C.C, F.A.H.A. Medical Director, Midwest Heart Specialists.
Peking University Dayi Hu Sept 16, IHF,Beijing, 2005 Atrial Fibrillation in China.
Assessment of Target Organ Damage: Established and Novel Methods Christian Delles BHF Glasgow Cardiovascular Research Centre Institute of Cardiovascular.
Evidence That D-dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients with Atrial Fibrillation during Oral Anticoagulant.
The value of echocardiography in stroke management Asjid Qureshi, Specialist registrar to Dr S Nussey.
Investigator Investigator: Sharma Kattel, MBBS Mentor: Mentor: Yuji Saito, MD, PhD, FACP, FACC Department of Internal Medicine Sisters of Charity Hospital.
Ventricular Diastolic Filling and Function
Jennifer Doria-del Castillo
Emily O’Brien, Emil Fosbol, Andrew Peng, Karen Alexander, Matthew Roe, Eric Peterson The Obesity Paradox: The Importance for Long-term Outcomes in Non-ST-Elevation.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
© Continuing Medical Implementation ® …...bridging the care gap Cardiovascular Aging.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Atrial Fibrillation What is New in the 2006 ACC/AHA/ESC Guidelines HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation. May 2007.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
Myocardial Ischemia Redefined: Optimal Care in CAD.
Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.
Multiple risk factors raise ischaemic stroke risk comparable to AF in the elderly: A large Chinese insurance analysis from 425,600 Chinese individuals.
Predictors of Cardiac Rehabilitation Referral in Coronary Artery Disease Patients: Results From the AHA’s Get With the Guidelines Program Todd M. Brown,
Specialized Atrial Fibrillation Clinic reduces cardiovascular morbidity and mortality in patients with atrial fibrillation Jeroen ML Hendriks, MSc Robert.
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,
1 Objectives, design and initial results from Phase I Nils Schoof Corp. Dept. Global Epidemiology, Boehringer Ingelheim GmbH.
Clinical Symptoms of Atrial Fibrillation in Different Ranges of QRS Duration Burda I.Yu., Yabluchansky N.I. Medical Clinics Chair National University of.
Restrictive Physiology is a Major Predictor of Poor Outcomes in Children with Hypertrophic Cardiomyopathy Shiraz A Maskatia MD, Jamie A Decker MD, Joseph.
MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.
Clinical Symptoms of Atrial Fibrillation according to QTc Interval Duration Kulik V.L., Yabluchansky N.I. Medical Clinics Chair National University of.
Presenter Disclosure Information Echocardiographic Tissue Doppler Imaging Is a Powerful Independent Prognosticator of Overall Mortality in the General.
Chapter 4: Cardiovascular Disease in Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Etiological Distribution of Chronic and Transient Atrial Fibrillation in Patients at Cantonal Hospital Zenica Enes Abdović 10 yrs Prospective Study, 29.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
VBWG Growth in heart disease, 2000–2050 Deaths Population Foot DK et al. J Am Coll Cardiol. 2000;35:
CHADS, SHMADS: What’s All This About Anticoagulation? COPYRIGHT © 2016, ALL RIGHTS RESERVED From the Publishers of.
TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.
Prevention of thromboembolism in AF ACC/AHA/ESC Guidelines Jin-Bae Kim, MD, PhD Arrhythmia Service, Division of Cardiology Cardiovascular Center, Kyung.
Prevalence of preserved left ventricular function among patients admitted for pulmonary oedema F.HAZIZA, N.COHEN, J.F.LANDAU, A.C.GUIOMARD. Service de.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. Benefit of Anticoagulation Unlikely in Patients With Atrial.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Sex Differences in Hospital Mortality in Adults With.
2016 Annual Data Report, Vol 1, CKD, Ch 4
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
Fig ACCF/AHA Guideline for the management of heart failure
– р<0.05 between baseline
All-cause mortality by treatment group
Screening and diagnosis of AF and stratifying stroke risk
Volume 1: Chronic Kidney Disease
Tyumen Cardiology Center, Russia Tyumen
No evidence that AF type significantly impacts stroke risk
Echocardiograms in syncope work-up
Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.
Volume 14, Issue 6, Pages (June 2017)
A. Epidemiology update:
Figure 4 BMI and mortality in patients with heart failure
Chapter 4: Cardiovascular Disease in Patients with CKD
Volume 14, Issue 6, Pages (June 2017)
Presenter: Wen-Ching Lan Date: 2018/10/17
Figure 2 Absolute difference in seasonal peak
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
Figure 8. Stroke prevention strategy in patients with AF
Traditional cardiovascular risk factors can cause cardiac disease in patients with IIM. Systemic and local inflammation may either have a direct effect.
Volume 14, Issue 6, Pages (June 2017)
Presentation transcript:

Etiology distribution of patients with atrial fibrilation by echocardiography: results from a prospective study in 3755 adults Enes Abdovic Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina

Purpose Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia 1 It is a disease of the elderly and it is common in patients with structural heart disease 1 Hypertension (HA), diabetes mellitus, myocardial infarction, heart failure (with impaired or preserved left ventricular systolic function), and valvular heart disease are recognized predisposing factors to AF 2,3,4 Objectives: To evaluate predisposing factors for development of AF in our hospital settings 1 Go AS, et al. JAMA 2001;285:2370–75. 2 Aidietis A, et al. Curr Pharm Des 2007;13:2545–55. 3 Grigioni F, et al. J Am Coll Cardiol 2002;40:84–92. 4 Olsson LG, et al. J Am Coll Cardiol 2006;47:1997–2004. Purpose

From June 2000 to February 2013, 3755 consecutive patients with AF were studied during echocardiographic check-up According to transthoracic echo, patients were divided in groups based on dominative underlying heart diseases Electrocardiographically documented AF was subdivided in two groups: transitory and chronic – Transitory AF fulfilled criteria for paroxysmal or persistent AF 1 – Chronic AF were cases of long-standing persistent or permanent AF 1 Binary logistic regression was used to investigate relationship of gender, age, hypertension, diabetes and underlying heart diseases with the type of AF Camm AJ, et al. Eur Heart J 2010;31:2369–2429. Methods

Results The median age was 72 years, age range between 16 and 96 years There were 51.4% of females. Chronic AF was observed in 68.3% pts. Lone AF was diagnosed in only 25 patients, mostly in younger males (median age 48 years, range 29–59, men 80%)

HHD=hypertensive heart disease; DCM=dilated cardiomyopathy; CAD=coronary artery disease; VHD=valvular heart disease; Lone=lone AF; HF=heart failure; AF=atrial fibrillation. Etiological distribution AF by echocardiography (3755 pts)

HHDDCMCADVHDLoneOTHERTOTAL N o of pts (%) 1511 (40.2)935 (24.9)522 (13.9)416 (11.1)25 (0.7)346 (9.2) 3755 (100) Females (%) 850 (56.3)394 (42.1)224 (42.9) 251 ( 60.3 ) 5 (20.0)207 (59.8) 1931 (51.4) Age, median (yrs) Age, range (yrs) BMI [kg/m 2 ] ±5 Transitory AF (%) 543 (35.9)200 (21.4)220 (42.2)84 (20.2) 18 ( 72.0 ) 126 (36.4) 1191 (31.7) Hypertension (%) 1511 ( 100 )624 ( 66.7 )348 ( 66.7 ) 198 (47.6)0172 (49.7) 2832 (75.4) Diabetes (%) 300 (19.9)168 (18.0) 158 ( 30.3 ) 37 (8.9)041 (11.9) 706 (18.8) Thyreoid disease (%) 0 (0)51 (5.5)27 (5.2)18 (4.3)0 181 ( 52.3 )240 (6.4) No=number; pts=patients; AF=atrial fibrillation; BMI=body mass index; HHD=hypertensive heart disease; DCM=dilated cardiomyopathy; CAD=coronary artery disease; VHD=valvular heart disease; Lone=lone AF. Comorbidities associated with AF

HHDDCMCADVHDLoneOTHERTOTAL N o of pts (%) 1511 (40.2)935 (24.9)522 (13.9)416 (11.1)25 (0.7)346 (9.2) 3755 (100) Females (%) 850 (56.3)394 (42.1)224 (42.9) 251 ( 60.3 ) 5 (20.0)207 (59.8) 1931 (51.4) Age, median (yrs) Age, range (yrs) BMI [kg/m 2 ] ±5 Transitory AF (%) 543 (35.9)200 (21.4)220 (42.2)84 (20.2) 18 ( 72.0 ) 126 (36.4) 1191 (31.7) Hypertension (%) 1511 ( 100 )624 ( 66.7 )348 ( 66.7 ) 198 (47.6)0172 (49.7) 2832 (75.4) LBBB(%) 95 (24.7) 209 ( 54.4 ) 36 (9.4)19 (5.0)025 (6.5) 384 (10.2) Galstones (%) 263 ( 45.7 ) 131 (22.8)84 (14.6)51 (8.9)045 (7.8) 575 (15.3) No=number; pts=patients; AF=atrial fibrillation; BMI=body mass index; HHD=hypertensive heart disease; DCM=dilated cardiomyopathy; CAD=coronary artery disease; VHD=valvular heart disease; Lone=lone AF. Comorbidities associated with AF

HHD=hypertensive heart disease; DCM=dilated cardiomyopathy; CAD=coronary artery disease; VHD=valvular heart disease; Lone=lone AF; HF=heart failure; AF=atrial fibrillation. AF and HA pts (2854=76%)

HHD=hypertensive heart disease; DCM=dilated cardiomyopathy; CAD=coronary artery disease; VHD=valvular heart disease; Lone=lone AF; HF=heart failure; AF=atrial fibrillation. AF and HF pts (1832=49%)

AF, typeChronic AFTransitory AFTotal No pts (%) 2564 ( 68.3 )1191 ( 31.7 ) 3755 (100%) Females (%) 1306 (50.9)625 (52.5) 1931 ( 51.4 ) Age,means&SD,yrs (range) 70±10 (16-96)68±11 (24-94)71±10 (16-96) BMI [kg/m 2 ] Hypertension (%) 1891 (73.8)941 (79.0) 2832 ( 75.4 ) Diabetes (%) 430 (16.8)191 (16.0) 706 ( 18.8 ) Coronary artery dysease (%) 594 (23.2)347 (29.1) 941 ( 25.1 ) Gallstones (%) 366 (14.3)203 (17.1) 569 ( 15.3 ) LBBB (%) 259 (10.1)124 (10.4) 383 ( 10.2 ) Stroke/TIA (%) 241 (9.4)67 (5.6) 308 ( 8.2 ) Thyroid dysfunction (%) 156 (6.1)84 (7.1) 240 ( 6.4 ) No=number; pts=patients; AF=atrial fibrillation; SD=standard deviation, yrs=years, BMI=body mass index; LBBB=left bundle branch block; TIA=transitory ischemic attack. Characteristics of patients with chronic vs. transitory AF

Results (2) Hypertensive heart disease (HHD) was the most common underlying heart disease (40.2%) followed by dilated cardiomyopathy (DCM), 24.9%, coronary artery disease (CAD), 13.9% and valvular heart disease (VHD), 11.1%. Thyroid gland disease was found in 240:6.3% of patients of which 52.9% was hypothyroidism (127 vs 113) Results (2)

Hypertension, diabetes and thyroid gland disease were found in 75.4%, 18.8% and 6.3% patients, respectively, mostly in females: (HA: 1556pts/2832=55.0%) (DM: 453pts/706=64.2%) (Thy.gl.disease: 193pts/240=80.4%) Results (3)

Risk of chronic atrial fibrillation (binary logistic regression model) HHD, hypertensive heart disease; DCM, dilated cardiomyopathy; CHD, coronary artery disease; VHD, valvular heart disease; Lone, lone atrial fibrillation; BMI, body mass index; HA, hypertension; DM, diabetes mellitus; TH, diseases of thyroid gland; IVB, intraventricular block.

Pts with/without Paroxismal AF Aged ≥65yrs and/or with LAE ≥ 25 and/or with IAB Group1 N= N= N=396 4 N=400 5 N=472 6 N=403 7 N=172 8 N=154 Age≥ IAB LAE AF/NO AF/YES AF(%)

CHA 2 DS 2 -VASc score ≥ 2 = 86.5% HHDDCMCADVHDOtherAgeFemale (%) Total ± ± 972 (17.8) ± 9256 (33.8) ± 7518 (50.2) ± 6600 (69.6) ± 6337 (79.5) ± 5119 (79.3) ± 327 (96.4) ± 310 (100.0) ± 02 (100.0)2

Conclusion Hypertension was by far the most prevalent associated medical condition in patients with AF AF without underlying heart disease was present in only 0.7%, mostly in younger patients, males, with transitory AF Almost 1/2 of pts with AF had HF and 59.2% had diastolic HF. Chronic AF was predominant in groups with advanced cardiac remodeling such as DCM and VHD, mostly in elderly Conclusion

Optimal treatement of HA as well as DM to prevent CAD and HF and to eliminate or at least postpone AF, the most common sustained cardiac arrhythmia Take Home Message